The trial will have 2,660 healthy adult subjects who are living in the same household as a person with a Covid-19 infection.
Alternative treatment options for recurrent and metastatic cervical cancer can transform the landscape and satisfy unmet needs.
As breakthrough mild-to-moderate Covid-19 cases continue to rise, all eyes are on Merck and Ridgeback Biotherapeutics’ antiviral.
Experts point to uncharted factors in COVID-19 vaccine research in kids as mRNA jab developers reveal their authorisation plans.
Race to be the first widely distributed protein subunit Covid-19 vaccine heats up with Vaxine nipping at Novavax’s heels.